Journals / Türk Kardiyoloji Derneği Arşivi / 2022 / Cilt: 50 - Sayı: 5

Mortality Trends from Ischemic Heart Disease in Turkey: 2009-2019

Türkiye İskemik Kalp Hastalığı Mortalite Trendi: 2009–2019

Pages
348–355
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, significant decreases have been observed in ischemic heart disease mortality rates, especially in the group over 65 years of age, in the last 5 years.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cardiovascular diseases still play an important role in public health and epidemiology as the leading cause of death worldwide.
📊
Key Findings & Data:This study aims to analyze the latest trends in ischemic heart disease mortality rates in Turkey by age, gender, and region using the Turkish Statistical Institute mortality data and evaluate the results.
💡
Conclusion & Impact:However, significant decreases have been observed in ischemic heart disease mortality rates, especially in the group over 65 years of age, in the last 5 years.
🔬Design:Research Article
📍Scope:2009-2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Cardiovascular diseases still play an important role in public health and epidemiology as the leading cause of death worldwide. Ischemic heart disease is the most common reason in this group. This study aims to analyze the latest trends in ischemic heart disease mortality rates in Turkey by age, gender, and region using the Turkish Statistical Institute mortality data and evaluate the results. Methods: We have obtained ischemic heart disease mortality data (2009-2019, in 12 regions) for Turkey from the mortality database of the Turkish Statistical Institute. Joinpoint analysis was used to estimate the annual percentage change and average annual percentage change to identify significant changes in trends. Results: The mean mortality rate for ischemic heart disease in Turkey was in an increasing trend from 2009 to 2019 (annual percentage change = 1.7 (−0.8; 4.3), P = .166). This increase was more pronounced in women (annual percentage change = 2.2 (−0.7; 5.2), P = .121) compared to men (annual percentage change = 1.4 (−1.1; 3.9), P = .235). When the period between 2015 and 2019 was evaluated, it was determined that ischemic heart disease mortality was in a decreasing trend in the groups over 65 years of age. The death rate due to ischemic heart disease is almost 2 times higher in men than in women in Turkey, and this rate ratio is highest in the Istanbul region. Conclusion: Although ischemic heart disease mortality trends have decreased globally, our country’s average is still on an increasing trend. However, significant decreases have been observed in ischemic heart disease mortality rates, especially in the group over 65 years of age, in the last 5 years.

Özet

Amaç: Kardiyovasküler hastalıklar dünya çapında önde gelen ölüm nedeni olarak halk sağlığı ve epidemiyolojisinde hala önemli bir rol oynamaktadır. Bu grupta en sık neden iskemik kalp hastalığıdır (İKH). Bu çalışma, Türkiye İstatistik Kurumu (TÜİK) ölüm verilerini kullanarak Türkiye'deki İKH ölüm oranlarındaki son eğilimleri yaşa, cinsiyete ve bölgeye göre analiz etmeyi ve sonuçları değerlendirmeyi amaçlamaktadır. Yöntemler: TÜİK ölüm veri tabanından İKH ölüm ve nüfus verileri (2009-2019 arasında, 12 bölge olarak) elde edildi. Trendlerdeki önemli değişiklikleri belirlemek için Joinpoint analizi kullanıldı ve yıllık yüzde değişim (APC), ortalama yıllık yüzde değişim (AAPC) oranları belirlendi. Bulgular: Türkiye'de İKH için ortalama ölüm oranı 2009'dan 2019'a kadar artan bir eğilim içindeydi (APC = 1,7 (−0,8; 4,3), P = ,166). Bu artış kadınlarda (APC = 2,2 (−0,7; 5,2), P = ,121) erkeklere göre (APC = 1,4 (−1,1; 3,9), P = ,235) daha belirgindi. 2015-2019 dönemi değerlendirildiğinde 65 yaş üstü gruplarda İKH mortalitesinin azalma eğiliminde olduğu belirlendi. Ayrıca, ülkemizde İKH nedeniyle halen erkeklerde kadınlara göre yaklaşık 2 kat daha fazla ölüm hızı olduğu ve bu oranın İstanbul bölgesinde en yüksek olduğu görülmektedir. Sonuç: İKH ölüm eğilimleri küresel olarak azalmasına rağmen, ülkemiz ortalaması hala artış eğilimindedir. Ancak son 5 yılda özellikle 65 yaş üstü grupta İKH ölüm oranlarında önemli düşüşler gözlenmiştir.

🔖

Cite This Article

YALIM, Z., DOĞAN, N., YALIM, S. A. (2022). Mortality Trends from Ischemic Heart Disease in Turkey: 2009-2019. Türk Kardiyoloji Derneği Arşivi, Cilt: 50 - Sayı: 5, 348–355. https://ajindex.com/articles/631771

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. World Health Organization. The Top 10 Causes of Death [WHO report] [internet]. Geneva
  2. Available at: https://ww w.who.int/ news- room/ fact- sheet s/det ail/t he-to p-10- cause s-of- death 2. Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980-2009. Circulation. 2016
  3. 133(20):1916-1926. [CrossRef] 3. Cayuela A, Cayuela L, Escudero-Martínez I, et al. Analysis of cerebrovascular mortality trends in Spain from 1980 to 2011. Neurologia. 2016
  4. 31(6):370-378. [CrossRef] 4. Márquez-Calderón S, Pérez Velasco L, Viciana-Fernández F, Fernández Merino JC. Tendencia de la mortalidad por edad y sexo en España (1981-2016). Cambios asociados a la crisis económica. Gac Sanit. 2020
  5. 34(3):230-237. [CrossRef] 5. Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Popul Health Metr. 2017
  6. 15(1):23. [CrossRef] 6. Barquera S, Pedroza-Tobías A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015
  7. 46(5):328-338. [CrossRef] 7. Turkish Statistical Institute database [internet]
  8. Available at: https://tu rksta tweb. tuik. gov.t r/Pre Tablo.do?a lt_id =1083 8. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: a New WHO Standard
  9. vol 10. Geneva World Heal Organ
  10. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000
  11. 19(3):335-351. [CrossRef] 10. Kim HJ, Luo J, Chen HS, et al. Improved confidence interval for average annual percent change in trend analysis. Stat Med. 2017
  12. 36(19):3059-3074. [CrossRef] 11. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009
  13. 28(29):3670-3682. [CrossRef] 12. Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004
  14. 60(4):1005- 1014. [CrossRef] 13. Wilmot KA, O’Flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States From 1979 Through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015
  15. 132(11):997-1002. [CrossRef] 14. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 198